PLoS ONE (Jan 2022)

Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study.

  • Gabriel S Tajeu,
  • Calvin L Colvin,
  • Shakia T Hardy,
  • Adam P Bress,
  • Bamba Gaye,
  • Byron C Jaeger,
  • Gbenga Ogedegbe,
  • Swati Sakhuja,
  • Mario Sims,
  • Daichi Shimbo,
  • Emily C O'Brien,
  • Tanya M Spruill,
  • Paul Muntner

DOI
https://doi.org/10.1371/journal.pone.0270675
Journal volume & issue
Vol. 17, no. 8
p. e0270675

Abstract

Read online

BackgroundMaintaining blood pressure (BP) control over time may contribute to lower risk for cardiovascular disease (CVD) among individuals who are taking antihypertensive medication.MethodsThe Jackson Heart Study (JHS) enrolled 5,306 African-American adults ≥21 years of age and was used to determine the proportion of African Americans that maintain persistent BP control, identify factors associated with persistent BP control, and determine the association of persistent BP control with CVD events. This analysis included 1,604 participants who were taking antihypertensive medication at Visit 1 and had BP data at Visits 1 (2000-2004), 2 (2005-2008), and 3 (2009-2013). Persistent BP control was defined as systolic BP ResultsAt Visit 1, 1,226 of 1,604 participants (76.4%) with hypertension had controlled BP. Overall, 48.9% of participants taking antihypertensive medication at Visit 1 had persistent BP control. After multivariable adjustment for demographic, socioeconomic, clinical, behavioral, and psychosocial factors, and access-to-care, participants were more likely to have persistent BP control if they were ConclusionLess than half of JHS participants taking antihypertensive medication had persistent BP control, putting them at increased risk for heart failure.